Zobrazeno 1 - 10
of 27
pro vyhledávání: '"P. R. Diamond"'
Autor:
P. R. Diamond, J. N. Airdrie, R. Hiller, A. Fraser, L. V. Hiscox, C. Hamilton-Giachritsis, S. L. Halligan
Publikováno v:
European Journal of Psychotraumatology, Vol 13, Iss 1 (2022)
Background: Understanding the course of post-traumatic stress disorder (PTSD) and the factors that impact this is essential to inform decisions about when and for whom screening and intervention are likely to be beneficial. Objective: To provide meta
Externí odkaz:
https://doaj.org/article/64104de0907942d6be12ba7ec1330909
Autor:
Anthony D. Elias, Alyse W. Staley, Monica Fornier, Gregory A. Vidal, Vida Alami, Sharon Sams, Nicole S. Spoelstra, Andrew Goodspeed, Peter Kabos, Jennifer R. Diamond, Elena Shagisultanova, Rosa I. Gallagher, Julia D. Wulfkuhle, Emanuel F. Petricoin, Kathryn L. Zolman, Tessa McSpadden, Kimberly R. Jordan, Jill E. Slansky, Virginia F. Borges, Dexiang Gao, Jennifer K. Richer
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-14 (2024)
Abstract Most ER+ breast cancers (BC) express androgen receptors (AR). This randomized phase II trial of 4 months of neoadjuvant fulvestrant (Fulv) alone or with enzalutamide (Combo) assessed whether adding AR blockade to Fulv would limit residual tu
Externí odkaz:
https://doaj.org/article/564ac0eba47340f495698648097af1b7
Autor:
Stephen G. Smoots, Anna R. Schreiber, Marilyn M. Jackson, Stacey M. Bagby, Adrian T A. Dominguez, Evan D. Dus, Cameron A. Binns, Morgan MacBeth, Phaedra A. Whitty, Jennifer R. Diamond, Todd M. Pitts
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-13 (2024)
Abstract Background Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with a poor prognosis. Doxorubicin is part of standard curative therapy for TNBC, but chemotherapy resistance remains an important clinical challenge. Boc
Externí odkaz:
https://doaj.org/article/e983610b7e904575a33047cfca75f04a
Autor:
Jarushka Naidoo, Maria L Ascierto, Matthew D Hellmann, Ding Wang, Susana Banerjee, Mayukh Das, Panagiotis Kourtesis, Jennifer R Diamond, Teresa Alonso-Gordoa, Sandip P Patel, Nathan E Standifer, Doug C Palmer, Lin-Yang Cheng, Benedito A Carneiro
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 2 (2024)
Background The combination of monalizumab (anti-NKG2A/CD94) and durvalumab (anti-programmed death ligand-1) may promote antitumor immunity by targeting innate and adaptive immunity. This phase 1/2 study of monalizumab and durvalumab evaluated safety,
Externí odkaz:
https://doaj.org/article/53d0d5cbaca340b3995a64a938291778
Autor:
Anthony D. Elias, Nicole S. Spoelstra, Alyse W. Staley, Sharon Sams, Lyndsey S. Crump, Gregory A. Vidal, Virginia F. Borges, Peter Kabos, Jennifer R. Diamond, Elena Shagisultanova, Anosheh Afghahi, Jose Mayordomo, Tessa McSpadden, Gloria Crawford, Angelo D’Alessandro, Kathryn L. Zolman, Adrie van Bokhoven, Yonghua Zhuang, Rosa I. Gallagher, Julia D. Wulfkuhle, Emanuel F. Petricoin III, Dexiang Gao, Jennifer K. Richer
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-10 (2023)
Abstract This clinical trial combined fulvestrant with the anti-androgen enzalutamide in women with metastatic ER+/HER2− breast cancer (BC). Eligible patients were women with ECOG 0–2, ER+/HER2− measurable or evaluable metastatic BC. Prior fulv
Externí odkaz:
https://doaj.org/article/ad0c82b5d82a4e81a6170a0a923d1435
Publikováno v:
Climate of the Past, Vol 19, Pp 865-881 (2023)
The lig127k-H11 simulation of the Paleoclimate Modelling Intercomparison Project (PMIP4) is run using the HadGEM3-GC3.1 model. We focus on the coupled system response to the applied meltwater forcing. We show here that the coupling between the atmosp
Externí odkaz:
https://doaj.org/article/f91503008994459d99eacb59bd8223b2
Autor:
Lisa A. Carey, Delphine Loirat, Kevin Punie, Aditya Bardia, Véronique Diéras, Florence Dalenc, Jennifer R. Diamond, Christel Fontaine, Grace Wang, Hope S. Rugo, Sara A. Hurvitz, Kevin Kalinsky, Joyce O’Shaughnessy, Sibylle Loibl, Luca Gianni, Martine Piccart, Yanni Zhu, Rosemary Delaney, See Phan, Javier Cortés
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract Patients with triple-negative breast cancer (TNBC) who relapse early after (neo)adjuvant chemotherapy have more aggressive disease. In the ASCENT trial, sacituzumab govitecan (SG), an antibody-drug conjugate composed of an anti-Trop–2 anti
Externí odkaz:
https://doaj.org/article/531a8b18c5434564aa5198960edea038
Publikováno v:
The Cryosphere, Vol 15, Pp 5099-5114 (2021)
The Hadley Centre Global Environment Model version 3 (HadGEM3) is the first coupled climate model to simulate an ice-free Arctic during the Last Interglacial (LIG), 127 000 years ago. This simulation appears to yield accurate Arctic surface temperatu
Externí odkaz:
https://doaj.org/article/92abfab4973e412c8e2ea2c00d510b64
Autor:
John J. Tentler, Julie Lang, Anna Capasso, Deog Joong Kim, Ely Benaim, Young B. Lee, Andrew Eisen, Stacey M. Bagby, Sarah J. Hartman, Betelehem W. Yacob, Brian Gittleman, Todd M. Pitts, Roberta Pelanda, S. Gail Eckhardt, Jennifer R. Diamond
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Background Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited systemic treatment options. RX-5902 is a novel anti-cancer agent that inhibits phosphorylated-p68 and thus attenuates nuclear β-catenin sign
Externí odkaz:
https://doaj.org/article/1dcda43bbcb945d6ae883320daa5d648
Autor:
Jing Lu, Eric Y. Hsiao, Mark M. Phillips, Christopher R. Burns, Chris Ashall, Nidia Morrell, Lawrence Ng, Sahana Kumar, Melissa Shahbandeh, Peter Hoeflich, E. Baron, Syed Uddin, Maximilian D. Stritzinger, Nicholas B. Suntzeff, Charles Baltay, Scott Davis, Tiara R. Diamond, Gaston Folatelli, Francisco Förster, Jonathan Gagné, Lluís Galbany, Christa Gall, Santiago González-Gaitán, Simon Holmbo, Robert P. Kirshner, Kevin Krisciunas, G. H. Marion, Saul Perlmutter, Priscila J. Pessi, Anthony L. Piro, David Rabinowitz, Stuart D. Ryder, David J. Sand
Publikováno v:
The Astrophysical Journal, Vol 948, Iss 1, p 27 (2023)
We present the largest and most homogeneous collection of near-infrared (NIR) spectra of Type Ia supernovae (SNe Ia): 339 spectra of 98 individual SNe obtained as part of the Carnegie Supernova Project-II. These spectra, obtained with the FIRE spectr
Externí odkaz:
https://doaj.org/article/fead5fdc64f740d39746b3ef7daa3425